Relationships Between Physical Activity and Bone Density in People Living with HIV: Results from the SATURN-HIV Study

被引:14
作者
Perazzo, Joseph D. [1 ,2 ]
Webel, Allison R. [3 ]
Alam, S. M. Khurshid [4 ]
Sattar, Abdus [4 ]
McComsey, Grace A. [5 ]
机构
[1] Univ Cincinnati, Nursing, Cincinnati, OH 45221 USA
[2] Case Western Reserve Univ, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Dept Epidemiol & Biostat, Sch Med, Cleveland, OH 44106 USA
[5] Case Western Reserve Univ, Case Rainbow Babies & Childrens Hosp, Case Med Ctr, Med & Pediat, Cleveland, OH 44106 USA
来源
JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE | 2018年 / 29卷 / 04期
基金
美国国家卫生研究院;
关键词
bone; exercise; HIV; osteoporosis; physical activity; BODY-MASS INDEX; MINERAL DENSITY; ANTIRETROVIRAL TREATMENT; INFECTION; INFLAMMATION; THERAPY; PREVALENCE; INITIATION; FRACTURE; SMOKING;
D O I
10.1016/j.jana.2018.03.004
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We conducted a cross-sectional secondary analysis of baseline data from the SATURN-HIV study (N=147; 78% male, 68% Black, median body mass index [BMI] 26.72 kg/m(2), 13% with osteopenia, HIV-1 < RNA, 1,000 copies/mL, stable antiretroviral therapy [ART]) to explore the relationship between physical activity (PA) and bone mineral density (BMD). We measured self-reported minutes of PA and BMD in the overall sample and subgroups based on national recommendations (>= 150 minutes/week). Forty-one (28%) participants met recommended PA levels. Higher intensity PA was associated with higher BMD at the total hip (r = 0.27, p = .09; n = 41; 28%) and lumbar spine (r = 0.32, p < .05), and predicted higher BMD at the hip (p < .01; controlling for age, BMI, ART). Lumbar spine BMD did not retain significance in the regression model. Moderate-tohigh intensity PA could prevent or mitigate excessive bone loss in people living with HIV. Copyright (C) 2018 Association of Nurses in AIDS Care
引用
收藏
页码:528 / 537
页数:10
相关论文
共 50 条
  • [1] American Heart Association, 2016, AM HEART ASS REC PHY
  • [2] Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection:: Indication of normalization of the bone-remodeling process during highly active antiretroviral therapy
    Aukrust, P
    Haug, CJ
    Ueland, T
    Lien, E
    Müller, F
    Espevik, T
    Bollerslev, J
    Froland, SS
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (01) : 145 - 150
  • [3] The HIV proteins Tat and Nef promote human bone marrow mesenchymal stem cell senescence and alter osteoblastic differentiation
    Beaupere, Carine
    Garcia, Marie
    Larghero, Jerome
    Feve, Bruno
    Capeau, Jacqueline
    Lagathu, Claire
    [J]. AGING CELL, 2015, 14 (04) : 534 - 546
  • [4] Low body weight mediates the relationship between HIV infection and low bone mineral density: A meta-analysis
    Bolland, Mark J.
    Grey, Andrew B.
    Gamble, Greg D.
    Reid, Ian R.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (12) : 4522 - 4528
  • [5] Moderate aerobic exercise (brisk walking) increases bone density in cART-treated persons
    Bonato, M.
    Bossolasco, S.
    Galli, L.
    Pavei, G.
    Testa, M.
    Bertocchi, C.
    Galvano, E.
    Balconi, G.
    Lazzarin, A.
    Merati, G.
    La Torre, A.
    Cinque, P.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 49 - 50
  • [6] Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip study
    Bonnet, Eric
    Ruidavets, Jean-Bernard
    Genoux, Anne
    Mabile, Laurence
    Busato, Florian
    Obadia, Martine
    Prevoteau, Francois
    Marchou, Bruno
    Massip, Patrice
    Marion-Latard, Fabrice
    Delpierre, Cyrille
    Bernard, Jacques
    Perret, Bertrand
    [J]. BMC INFECTIOUS DISEASES, 2013, 13
  • [7] Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir
    Brown, Todd T.
    Moser, Carlee
    Currier, Judith S.
    Ribaudo, Heather J.
    Rothenberg, Jennifer
    Kelesidis, Theodoros
    Yang, Otto
    Dube, Michael P.
    Murphy, Robert L.
    Stein, James H.
    McComsey, Grace A.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (08) : 1241 - 1249
  • [8] Body Composition, Soluble Markers of Inflammation, and Bone Mineral Density in Antiretroviral Therapy-Naive HIV-1-Infected Individuals
    Brown, Todd T.
    Chen, Yun
    Currier, Judith S.
    Ribaudo, Heather J.
    Rothenberg, Jennifer
    Dube, Michael P.
    Murphy, Robert
    Stein, James H.
    McComsey, Grace A.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 63 (03) : 323 - 330
  • [9] Bone turnover, osteoprotegerin/RANKL and inflammation with antiretroviral initiation: tenofovir versus non-tenofovir regimens
    Brown, Todd T.
    Ross, Allison C.
    Storer, Norma
    Labbato, Danielle
    McComsey, Grace A.
    [J]. ANTIVIRAL THERAPY, 2011, 16 (07) : 1063 - 1072
  • [10] Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen
    Brown, Todd T.
    McComsey, Grace A.
    King, Martin S.
    Qaqish, Roula B.
    Bernstein, Barry M.
    da Silva, Barbara A.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 (05) : 554 - 561